Effects of Sensorimotor Training With Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer Patients
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age30-65
SponsorRiphah International University
About this trial
Chemotherapy-Induced Peripheral Neuropathy (CIPN) is a prevalent and clinically relevant side effect of chemotherapy in breast cancer patients. It occurs in 30-70% of cases. It can cause various sensory and motor symptoms. Specific exercise interventions have proven promising to target relevant symptoms. Therefore, the objective of this study is to determine the effects of Sensorimotor training on pain intensity, perceived balance confidence, and functional exercise capacity with chemotherapy-induced peripheral neuropathy in breast cancer patients.
Eligibility criteria
Qualifiers
Females with invasive ductal carcinoma, stages I-III
Age ranged between 30-65 years
3-6 months post breast cancer diagnosis
Those who have completed chemotherapy treatment and are medically stable
Disqualifiers
Women with additional types of cancer besides breast cancer
Chronic medical conditions such as poorly controlled diabetes (6)
Significant neurological (multiple sclerosis) or cardiopulmonary disease (myocardial infarction < 3 months) that may affect performance (6)
Unstable bone metastasis
Trial design
Treatments tested in this trial
- Sensorimotor Training Exercise
- Conventional Exercise Therapy
Treatment groups
24 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov